In the Euro‑Lupus regimen, should cyclophosphamide be given immediately after the pulse methylprednisolone course or two weeks later?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Euro-Lupus Cyclophosphamide Timing

In the Euro-Lupus regimen, cyclophosphamide 500 mg is administered every 2 weeks for 6 doses (fortnightly), starting immediately after the initial pulse methylprednisolone course, not delayed by two weeks. 1, 2

Standard Euro-Lupus Protocol

The original and validated Euro-Lupus regimen consists of:

  • Initial pulse steroids: Methylprednisolone 500-1000 mg IV daily for 3 days 1
  • Cyclophosphamide: 500 mg IV every 2 weeks × 6 doses, beginning immediately after pulse steroids 1, 2
  • Oral prednisone: Started concurrently at 0.5 mg/kg/day and tapered 1
  • Maintenance: Azathioprine or mycophenolate mofetil after completing cyclophosphamide 1, 2

Key Timing Considerations

The cyclophosphamide pulses are given at 2-week intervals starting right after the methylprednisolone pulses are completed - there is no additional 2-week waiting period before initiating cyclophosphamide. 1, 2 This fortnightly schedule (every 14 days) continues for all 6 doses, resulting in a total induction duration of approximately 10-12 weeks. 2, 3

The 10-year follow-up data from the Euro-Lupus Nephritis Trial confirmed that this low-dose regimen (total cumulative cyclophosphamide dose of 3 grams) achieved comparable efficacy to high-dose NIH protocols while significantly reducing gonadal toxicity and infection risk. 2, 3

Enhanced Protocol Variation

A more recent modification adds methylprednisolone 125 mg IV with each cyclophosphamide dose (given fortnightly), which has shown improved complete response rates (86% vs 56% with cyclophosphamide alone) while allowing lower oral prednisone doses and reducing glucocorticoid-related toxicity. 4 This enhanced regimen maintains the same fortnightly cyclophosphamide schedule without delay.

Important Caveats

  • The Euro-Lupus regimen was primarily validated in Caucasian patients of European descent with generally less severe disease 1
  • For non-Caucasian populations or patients with severe disease features (rapidly rising creatinine, crescentic glomerulonephritis), higher-dose cyclophosphamide regimens or alternative agents like mycophenolate mofetil may be more appropriate 1
  • The majority of patients in long-term Euro-Lupus follow-up (75%) remained on maintenance steroids, which contributed to sustained remission 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pro: Cyclophosphamide in lupus nephritis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.